Biosyent Inc (BIOYF) Stock Price & News

All values in CAD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	12.22M	9.67M	13.91M	19.87M
Cost of goods sold	2.95M	2.23M	3.74M	5.90M
Cost of revenue	2.95M	2.23M	3.74M	5.90M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.84M	5.22M	6.23M	8.83M
Operating expense	5.84M	5.22M	6.72M	9.88M
Total operating expenses	8.79M	7.45M	10.46M	15.78M
Operating income	3.43M	2.22M	3.45M	4.09M
Other non operating income	-	-	-	-
EBT including unusual items	3.65M	2.48M	3.29M	3.97M
EBT excluding unusual items	3.65M	2.48M	3.56M	4.13M
Income tax expense	967.10K	486.60K	940.48K	1.12M
Effective tax rate	26.50%	19.63%	28.63%	28.23%
Other operating expenses	-	-	-	-
Net income	2.68M	1.99M	2.34M	2.85M
Net profit margin	21.95%	20.59%	16.86%	14.34%
Earnings per share	-	-	-	-
Interest and investment income	231.39K	187.77K	166.79K	94.41K
Interest expense	-12.14K	-11.48K	-31.62K	-51.37K
Net interest expenses	219.25K	176.29K	135.18K	43.04K
Depreciation and amortization charges	-	-	94.11K	153.87K
EBITDA	3.65M	2.41M	3.88M	5.05M
Gain or loss from assets sale	-	-	-	-

Finance